Kuros Biosciences Ltd. KURN
SIX · Switzerland · Health Technology
CHF 18.85+0.56 (+3.06%)
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Ad-hoc announcement pursuant to Article 53 of the SIX listing rulesKuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability Schlieren (Zurich), Switzerland, August 13, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the first half of 2026.Financial HighlightsTotal Medical Device sales increased 45% to USD 92.4 million in H1 2026 (H1 20
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, June 17, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today’s Capital Markets Day on Wednesday, June 17, 2026, at 9am CEST, at the Mandarin Oriental Savoy, Zürich, Switzerland. The event will also be available virtually via live webcast. Capital Markets Day wil
As European markets navigate a period of uncertainty, marked by mixed economic signals and geopolitical tensions, investors are keenly observing growth companies that demonstrate resilience. In such an environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and future prospects.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.